Harmony Biosciences Inc. (HRMY)
NASDAQ: HRMY
· Real-Time Price · USD
33.88
0.49 (1.47%)
At close: May 15, 2025, 10:45 AM
Company Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States.
Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020.
Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Harmony Biosciences Inc.
| Country | United States |
| IPO Date | Aug 19, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 268 |
| CEO | Dr. Jeffrey M. Dayno M.D. |
Contact Details
Address: 630 West Germantown Pike Plymouth Meeting, Pennsylvania United States | |
| Website | https://www.harmonybiosciences.com |
Stock Details
| Ticker Symbol | HRMY |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001802665 |
| CUSIP Number | 413197104 |
| ISIN Number | US4131971040 |
| Employer ID | 82-2279923 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jeffrey M. Dayno M.D. | President, Chief Executive Officer & Director |
| Sandip S. Kapadia CPA, M.B.A. | Executive Vice President, Chief Administrative Officer & Chief Financial Officer |
| Andrew Serafin J.D., M.B.A. | Executive Vice President & Chief Strategy Officer |
| Audrey Murphy SPHR | Chief Human Resources Officer |
| Brennan Doyle | Vice President & Head of Investor Relations |
| Cate McCanless | Senior Vice President & Chief Corporate Affairs Officer |
| Christian Ulrich J.D. | General Counsel & Corporate Secretary |
| Dr. Kumar Budur M.D., M.S. | Executive Vice President and Chief Medical & Scientific Officer |
| Jeffrey S. Aronin | Founder & Non-Executive Chairman |
| Tricia Glover | Chief Compliance Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 09, 2025 | 4 | Filing |
| May 06, 2025 | 10-Q | Quarterly Report |
| May 06, 2025 | 8-K | Current Report |
| Apr 29, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Apr 16, 2025 | 4 | Filing |
| Apr 16, 2025 | 3 | Filing |
| Apr 04, 2025 | 4 | Filing |
| Apr 04, 2025 | 3 | Filing |
| Apr 04, 2025 | ARS | Filing |
| Apr 04, 2025 | DEFA14A | Filing |